Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic nephropathies: therapeutic aspects].

C Bulliard1, E Fontana, J Ruiz

  • 1Division d'endocrinologie, diabétologie et du métabolisme, Département de médecine interne, Centre Hospitalier Universitaire Vaudois, Lausanne.

Praxis
|February 1, 2002
PubMed
Summary

Diabetic nephropathy, though declining, remains a leading cause of kidney failure. Comprehensive management of diabetes mellitus and its risk factors is crucial for reducing end-stage renal disease and mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.

ESMO open·2026
Same author

European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'.

ESMO gastrointestinal oncology·2026
Same author

Association or causation: still more questions than answers in early-onset gastrointestinal cancers.

ESMO gastrointestinal oncology·2026
Same author

Current practices and challenges in implementing precision medicine for upper gastrointestinal cancers in European academic centers: an EORTC survey.

ESMO gastrointestinal oncology·2026
Same author

Benefits from early trial involvement in metastatic colorectal cancer: outcomes from the phase I unit at the Sarah Cannon Research Institute UK.

ESMO gastrointestinal oncology·2026
Same author

Empathy in mild cognitive impairment: a preliminary clinical comparative study in Southern Switzerland using the interpersonal reactivity index (IRI) and the story-based empathy task (SET).

Frontiers in aging neuroscience·2025

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Context:

  • Diabetes mellitus is a growing global health concern.
  • Diabetic nephropathy is the primary cause of end-stage renal failure.
  • Despite declining incidence, diabetic nephropathy prevalence is increasing due to higher diabetes rates and improved longevity.

Purpose:

  • To review the natural history of diabetic nephropathy.
  • To explore genetic and non-genetic factors influencing its progression.
  • To discuss the impact of hypertension, hyperglycemia, dyslipidemia, proteinuria, and tobacco use.

Summary:

  • The review details diabetic nephropathy's progression, highlighting key risk factors.
  • It emphasizes that managing these promoters is vital for preventing end-stage renal failure.

Related Experiment Videos

  • A holistic approach including cardiovascular risk management is essential.

    • Impact:

    • Comprehensive management strategies can mitigate the risk of end-stage renal failure in diabetic patients.
    • Integrating cardiovascular risk factor management and screening reduces high mortality rates.
    • This review provides insights for clinicians and researchers managing diabetic nephropathy.